Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: pro

Inflamm Bowel Dis. 2005 Feb;11(2):197-9. doi: 10.1097/00054725-200502000-00014.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adolescent
  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Azathioprine / administration & dosage
  • Azathioprine / therapeutic use*
  • Child
  • Child Welfare
  • Clinical Trials as Topic
  • Crohn Disease / drug therapy*
  • Crohn Disease / immunology*
  • Decision Making
  • Drug Therapy, Combination
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use*
  • Mercaptopurine / administration & dosage
  • Mercaptopurine / therapeutic use*
  • Quality of Life
  • Severity of Illness Index

Substances

  • Adrenal Cortex Hormones
  • Immunosuppressive Agents
  • Mercaptopurine
  • Azathioprine